amaryllidacea
alkaloid
transdihydrolycoricidin
three
analogu
produc
via
asymmetr
chemic
synthesi
alkaloid
prove
superior
acyclovir
current
standard
herp
simplex
viru
type
infect
compound
potent
inhibit
lytic
infect
significantli
reduc
reactiv
potent
inhibit
varicella
zoster
viru
vzv
lytic
infect
configur
defin
secondari
alcohol
prove
crucial
efficaci
inhibit
lytic
infect
figur
structur
antivir
amaryllidacea
alkaloid
alkaloid
natur
product
compound
access
via
total
synthesi
lycorin
pseudolycorin
pancratistatin
narciclasin
transdihydrolycoricidin
letter
pubsacsorgacsmedchemlett
h
erp
simplex
viru
type
ubiquit
dna
viru
herpesvirida
famili
caus
substanti
human
morbid
mortal
seroposit
rate
exceed
elder
caus
recurr
cold
sore
corneal
infect
blind
rare
enceph
establish
latent
infect
sensori
neuron
refractori
clearanc
produc
intract
lifelong
reservoir
cycl
lytic
infect
though
acut
infect
readili
treatabl
nontox
nucleosid
analogu
acyclovir
acv
drug
success
elimin
latent
infect
addit
grow
acv
drug
resist
fuel
search
novel
antivir
plant
amaryllidacea
famili
produc
numer
structur
divers
biolog
activ
alkaloid
particular
alkaloid
lycoran
subclass
includ
lycorin
pseudolycorin
pancratistatin
analogu
unsatur
deriv
narciclasin
deoxi
analogu
demonstr
varieti
antivir
activ
figur
restrict
avail
natur
lycoranetyp
alkaloid
absenc
rapid
synthet
rout
toward
structur
analogu
imped
develop
antivir
pharmacophor
develop
synthet
strategi
allow
rapid
access
function
dens
stereochem
defin
core
enabl
asymmetr
synthesi
biolog
activ
natur
product
open
synthet
entri
nonnatur
analogu
analogu
expand
structur
divers
avail
biolog
assess
facilit
discoveri
previous
unknown
effect
improv
understand
structur
requir
biolog
activ
recent
report
total
asymmetr
synthesi
transdihydrolycoricidin
employ
converg
stepwis
organocatalyt
michaelaldol
annul
substitut
aceton
deriv
onto
function
cinnamaldehyd
catalyz
diarylprolinol
ether
tm
trimethylsilyl
crucial
step
allow
asymmetr
entri
function
nitrogensubstitut
cyclohexan
one
step
could
conduct
gram
scale
case
compound
convert
alkaloid
short
sequenc
subsequ
transform
involv
epoxid
diol
instal
scheme
order
extend
michaelaldol
methodolog
obtain
oxygen
cyclohexan
deriv
directli
investig
reaction
nonsymmetr
benzoyloxyazidoaceton
deriv
scheme
delight
reaction
found
proceed
highli
regioselect
fashion
initi
michaeladdit
fulli
direct
azido
group
allow
direct
entri
cyclohexanol
complex
cyclohexan
product
obtain
directli
precipit
form
reaction
isol
yield
requir
chromatograph
purif
reaction
also
prove
highli
diastereoselect
dr
major
diastereom
essenti
homochir
ee
rel
absolut
stereochemistri
major
cycloadduct
determin
shown
data
confirm
singl
crystal
xray
analysi
analogu
see
scheme
support
inform
rapid
access
compound
seri
avail
comparison
natur
product
convert
compound
natur
product
shown
scheme
catalyt
hydrogen
azido
group
situ
protect
methoxycarbonylamino
keton
success
achiev
use
dimethoxydicarbon
dmdc
keton
subject
axial
hydrid
reduct
desir
alcohol
protect
alongsid
hydroxyl
group
give
orthogon
protect
triol
cycliz
achiev
use
banwel
modif
reaction
give
high
regioselect
minor
diastereom
detect
deprotect
give
target
molecul
access
compound
exceedingli
effici
given
onepot
asymmetr
entri
azidocyclitol
high
yield
obtain
convers
shown
scheme
analogu
acycl
intermedi
prepar
via
similar
michaelaldol
annul
azidoaceton
cinnamaldehyd
deriv
outlin
supplement
scheme
synthet
access
natur
alkaloid
analogu
acycl
compound
onhand
conjunct
natur
product
proceed
antivir
assess
base
earlier
report
show
activ
alkaloid
deriv
amaryllidacea
initi
evalu
efficaci
compound
infect
employ
genet
engin
construct
incorpor
enhanc
green
fluoresc
protein
egfp
red
fluoresc
protein
rfp
report
gene
whose
express
driven
viral
promot
glycoprotein
c
gc
respect
immedi
earli
ie
gene
gc
express
onset
viral
dna
replic
vero
cell
initi
infect
multipl
infect
moi
cultur
h
postinfect
hpi
media
contain
compound
acv
flow
cytometri
analysi
fc
show
percentag
egfp
posit
egfp
cell
infect
cultur
expos
reduc
respect
compar
untreat
infect
cultur
hpi
figur
acv
caus
reduct
egfp
cell
product
infect
estim
cultur
supernat
viru
yield
reduct
assay
use
vero
cell
hpi
also
suppress
cell
cultur
treat
similar
acv
figur
convers
compound
inhibit
infect
figur
furthermor
compound
suppress
product
infect
figur
result
reveal
critic
role
play
group
found
natur
product
requir
antivir
activ
scheme
asymmetr
organocatalyt
michaelaldol
cycloaddit
reaction
cinnamaldehyd
deriv
azidoaceton
deriv
allow
onestep
access
stereochem
defin
cyclohexanol
permit
rapid
asymmetr
entri
natur
alkaloid
reaction
lead
permit
access
deoxi
analogu
human
natur
host
human
neuron
known
reservoir
infect
compound
also
test
neuron
deriv
human
induc
pluripot
stem
cell
ipsc
ipscneuron
cultur
infect
genet
engin
construct
moi
subsequ
treat
acv
hpi
fc
analysi
show
reduct
percentag
egfp
cell
ipscneuron
cultur
treat
hpi
respect
acv
caus
modest
inhibit
figur
suppress
product
infect
ipscneuron
treat
compound
also
note
figur
next
use
fluoresc
situ
hybrid
fish
investig
whether
test
compound
affect
dna
replic
ipscneuron
similar
acv
fish
analysi
infect
ipscneuron
treat
acv
indic
hybrid
dna
wherea
infect
cell
treat
show
numer
hybrid
signal
suggest
ongo
viral
replic
supplement
figur
thu
compound
appear
exert
inhibitori
effect
dna
replic
like
acv
sinc
compound
simplest
analogu
function
stereochem
perspect
exhibit
novel
antivir
effect
readili
avail
total
synthet
strategi
select
analys
ipscneuron
infect
describ
dna
extract
hpi
quantit
pcr
qpcr
analysi
indic
dramat
reduct
viral
dna
copi
number
cell
treat
reduct
acv
reduct
compar
infect
untreat
cell
supplement
figur
immedi
earli
gene
essenti
viral
replic
therefor
util
rtqpcr
test
express
viral
dna
polymeras
hpi
infect
ipscneuron
treat
acv
substanti
reduct
express
viral
dna
polymeras
observ
ipscneuron
treat
acv
supplement
figur
reduct
express
level
confirm
western
blot
supplement
figur
taken
togeth
result
indic
influenc
one
stage
lytic
cycl
dna
replic
altern
reduc
express
ie
gene
viral
dna
polymeras
drug
may
result
inhibit
multipl
round
viral
replic
drug
ad
hpi
unnecessari
test
effect
viral
entri
concentr
caus
decreas
percentag
egfp
cell
estim
similar
acv
ec
supplement
figur
concentr
nm
acv
significantli
affect
ipscneuron
viabil
supplement
figur
given
remark
activ
next
investig
effect
nonlyt
infect
adapt
convent
rodent
latenc
protocol
previous
use
antivir
cocktail
e
uml
day
induc
quiescent
infect
ipscneuron
mimic
sever
aspect
latenc
report
day
withdrawn
low
level
product
infect
note
figur
could
reactiv
use
sodium
butyr
nab
mm
histon
deacetylas
inhibitor
cell
treat
show
greater
increas
respect
percentag
egfp
cell
compar
treat
cell
withdraw
agent
day
figur
infecti
viral
particl
nevertheless
undetect
supernat
harvest
cell
figur
unexpectedli
egfp
mean
fluoresc
intens
mfi
cell
treat
approxim
lower
treat
cell
day
drug
withdrawn
figur
cell
treat
also
differ
treat
cell
follow
incub
nab
wherea
latter
show
robust
reactiv
respect
percentag
egfp
cell
egfp
mfi
cell
treat
show
signific
reactiv
figur
b
similarli
proport
egfprfp
cell
egfprfp
mfi
significantli
reduc
cell
treat
treatment
nab
compar
cell
treat
figur
b
taken
togeth
experi
suggest
repress
induc
distinct
bvdu
acv
reactiv
extent
nab
explor
whether
antivir
effect
extend
beyond
compar
acv
varicella
zoster
viru
vzv
anoth
common
herp
viru
caus
chicken
pox
shingl
neuralgia
use
vzv
construct
express
luciferas
late
promot
retin
pigment
epitheli
cell
infect
vzv
pfu
well
compound
acv
ad
hpi
assay
hpi
compound
caus
reduct
luciferas
count
per
second
show
ec
acv
caus
reduct
supplement
figur
signific
chang
cell
viabil
observ
test
concentr
acv
supplement
figur
variou
antivir
activ
amaryllidacea
alkaloid
report
last
three
decad
comprehens
evalu
antivir
activ
sever
alkaloid
reveal
pancratistatin
narciclasin
transdihydrolycoricidin
analogu
activ
japanes
enceph
yellow
fever
dengu
virus
antivir
activ
lycorin
avian
influenza
viru
recent
report
lycorin
also
inhibit
rnavirus
includ
sever
acut
respiratori
syndrom
sar
associ
coronaviru
polioviru
west
nile
viru
present
work
significantli
expand
knowledg
antivir
activ
alkaloid
identifi
deriv
exhibit
novel
distinct
divers
inhibitori
effect
vzv
infect
superior
acv
facil
method
report
rapid
asymmetr
synthesi
natur
nonnatur
lycorinetyp
alkaloid
permit
discoveri
clear
pattern
demonstr
crucial
role
play
hydroxi
substitu
alkaloid
requir
antivir
activ
compound
contain
stereochemistri
demonstr
potent
antivir
activ
compound
deriv
significantli
less
activ
allow
identif
alkaloid
function
minimum
antivir
pharmacophor
applic
har
ipscneuron
base
platform
addit
pathogen
current
addit
analogu
prepar
refin
synthet
protocol
activ
investig
importantli
latent
infect
lifelong
drugrefractori
multipl
effect
compound
infect
includ
abil
significantli
reduc
reactiv
quiescenc
motiv
addit
studi
viral
entri
viral
heterochromatin
addit
studi
need
evalu
whether
compound
alon
combin
current
known
antiherpet
drug
repress
irrevers
confer
protect
immunocompromis
individu
may
risk
acvresist
patient
renal
failur
support
inform
avail
free
charg
ac
public
websit
doi
full
detail
biolog
synthet
procedur
character
data
compound
report
crystallograph
data
compound
deposit
ccdc
pdf
